Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma

Cell & Gene: The Podcast

English - March 03, 2022 09:00 - 18 minutes - 13 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: REGENXBIO's Nina Hunter, Ph.D. Details the Accelerated Approval Pathway for Gene Therapies

Next Episode: Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian

We love to hear from our listeners. Send us a message.

Cue Biopharma's Anish Suri, Ph.D., explains why the clinical-stage biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer.